S. Insúa
Complejo Hospitalario Universitario de Santiago(ES)
Publications by Year
Research Areas
Ocular Diseases and Behçet’s Syndrome, Systemic Lupus Erythematosus Research, Retinal and Optic Conditions, Retinal Diseases and Treatments, Autoimmune and Inflammatory Disorders Research
Most-Cited Works
- → Anti-TNF- therapy in patients with refractory uveitis due to Behcet's disease: a 1-year follow-up study of 124 patients(2014)122 cited
- → Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 Cases(2019)106 cited
- → Prevalence of primary Sjögren's syndrome in patients with multiple sclerosis(1990)68 cited
- → Anti-TNF vs tocilizumab in refractory uveitic cystoid macular edema due to Behcet's disease. Multicenter study of 49 patients(2022)20 cited
- → Comparative Study of Adalimumab, Infliximab and Certolizumab Pegol in the Treatment of Cystoid Macular Edema Due to Behçet’s Disease(2024)4 cited
- → FRI0213 Anti-TNF therapy in refractory uveitis of behcet's syndrome. A multicenter study of 63 patients(2012)2 cited
- → FRI0269 COMPARATIVE STUDY OF INFLIXIMAB VERSUS ADALIMUMAB IN REFRACTORY UVEITIS DUE TO BEHÇET'S DISEASE. NATIONAL MULTICENTER STUDY OF 177 CASES(2019)2 cited
- → SAT0149 Biologic Therapy: Switching and Dose Modification in Refractory Uveitis of Behcet'S Syndrome. Multicenter Study of 108 Patients(2013)1 cited
- → FRI0607 Long-term and optimization of infliximab in refractory uveitis associated to behÇet disease. multicentre study of 100 patients(2017)1 cited
- → SAT0148 Short and Long-Term Biological Therapy in Refractory Uveitis of Behcet'S Syndrome. Multicenter Study of 108 Patients(2013)1 cited